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ABSTRACT   
 
We investigated effects of the ryanodine receptor (RyR) modulator caffeine on Na
+
 current 
(INa) activation and inactivation in intact loose-patch clamped murine skeletal muscle fibres 
subject to a double pulse procedure. INa activation was examined using 10-ms depolarising, 
V1, steps to varying voltages 0-80 mV positive to resting membrane potential. The 
dependence of the subsequent, INa inactivation on V1 was examined by superimposed, V2, 
steps to a fixed depolarising voltage. Current-voltage activation and inactivation curves 
indicated that adding 0.5 and 2 mM caffeine prior to establishing the patch seal respectively 
produced decreased (within 1 min) and increased (after ~2 min) peak INa followed by its 
recovery to pretreatment levels (after ~40 and ~30 min respectively). These changes 
accompanied negative shifts in the voltage dependence of INa inactivation (within 10 min) 
and subsequent superimposed positive activation and inactivation shifts, following 0.5 mM 
caffeine challenge. In contrast, 2 mM caffeine elicited delayed negative shifts in both 
activation and inactivation. These effects were abrogated if caffeine was added after 
establishing the patch seal or with RyR block by 10 μM dantrolene. These effects precisely 
paralleled previous reports of persistently (~10 min) increased cytosolic [Ca
2+
] with 0.5 mM, 
and an early peak rapidly succeeded by persistently reduced [Ca
2+
] likely reflecting gradual 
RyR inactivation with ≥1.0 mM caffeine. The latter findings suggested inhibitory effects of 
even resting cytosolic [Ca
2+
] on INa. They suggest potentially physiologically significant 
negative feedback regulation of RyR activity on Nav1.4 properties through increased or 
decreased local cytosolic [Ca
2+
], Ca
2+
-calmodulin and FKBP12.  
 
INTRODUCTION 
Skeletal muscle excitation-contraction coupling involves triggering of a Nav1.4 mediated 
action potential. This is detected by voltage-dependent transverse tubular Cav1.1 that 
undergoes transitions resulting in an allosterically-activated ryanodine receptor (RyR) 
mediated release of sarcoplasmic reticular (SR) Ca
2+
 thereby increasing cytosolic free Ca
2+
 
concentration, [Ca
2+
]i, Recent findings have been suggestive of feedback mechanisms 
through which downstream events in this feedforward sequence might conversely affect 
Nav1.4 function. However, many of these reports provided structural rather than functional 
evidence, or involved experiments in cell lines or isolated cultured cells. They thus provide 
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necessary rather than sufficient evidence for the actual operation of Ca
2+
 mediated feedback 
mechanisms in working muscle in vivo. Few available reports examined the existence and 
properties of RyR-mediated feedback actions on Nav1.4 function in intact in situ skeletal 
myocytes particularly those directly targeting the RyR mediated Ca
2+
 release process..  
First, Nav1.4 possesses several potential Ca
2+
 and calmodulin (CaM) binding or modulation 
sites. These include: (a) one or more Ca
2+
-binding C-terminal EF-like hand motifs
1
; (b) a C-
terminal isoleucine-glutamine (IQ) domain that could bind CaM following combination of 
Ca
2+
 with CaM’s own EF-hand motifs2; (c) a III-IV loop Ca2+/CaM-binding site3; (d) sites 
phosphorylatable by CaM kinase II (CaMKII) themselves regulated by Ca
2+
/CaM
4
 and (e) a 
phosphorylation site for phosphokinase C (PKC)
5
.  
Secondly, single-cell patch-clamp studies reported that both rapid photo-release of caged 
Ca
2+
, raising [Ca
2+
]i to ~2 µM, and Ca
2+
 overspill from neighbouring Ca
2+
 channels, reduced 
peak Na
+
 currents, INa, in Nav1.4-transfected HEK293 cells and skeletal muscle cell lines. 
These effects were abrogated by intracellular BAPTA
6
. Additionally, CaM expression in the 
transgenic cells negatively shifted the voltage-dependences of Nav1.4 inactivation. Both the 
reduction of peak INa, and this negative shift in voltage dependence, were abolished by 
mutations in either the Ca
2+
-binding-EF hands on CaM or the Nav1.4 C-terminal IQ 
domain
2,6–8
. These results implicated CaM binding to the IQ domain in Nav1.4 modulation by 
[Ca
2+
]i.   
Thirdly, increases in free intracellular concentrations of FK506 binding protein, [FKBP12]i 
resulting from reductions in its affinity for RyR subunits associated with RyR opening
9,10
, 
positively shifted activation and inactivation voltage dependences in cardiomyocyte Nav1.5 
11
, thought closely homologous to Nav1.4
4
. This likely involves an indirect effect; co-
immunoprecipitation assays appear to exclude direct FKBP12 – Nav1.5 interactions
11
.  
 
However, fewer reports are available on such [Ca
2+
]i-dependent Nav1.4 modulation in intact 
in situ skeletal myocytes. Loose-patch clamp studies reported that carbonyl cyanide-3-
chlorophenylhydrazone
12
 and 8-(4-chlorophenylthio)adenosine-3',5'-cyclic monophosphate 
challenge
13
 reduced INa. These effects were reversed by the Ca
2+
 buffer BAPTA and RyR 
blocker dantrolene respectively. However, these agents affected [Ca
2+
]i indirectly through 
modifying mitochondrial Ca
2+
 release or altering RyR activity through CAMKII-dependent 
pathways via Exchange protein directly activated by cAMP (Epac). 
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We here test the hypothesis that the direct RyR-SR Ca
2+
 channel modulator caffeine 
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modifies INa in intact mammalian skeletal muscle fibres. We utilised experimental protocols 
previously shown to accomplish contrasting effects of 0.5 and > 1.0 mM caffeine challenge 
on spectrofluometrically measured resting skeletal myocyte [Ca
2+
]i
15–17
. Thus, in isolated 
rabbit skeletal SR or murine skeletal muscle fibre preparations, caffeine (0.5 mM) caused 
increased [Ca
2+
]i (to ~300 nM) from resting levels (typically ~106 ± 2 nM in rat 
gastrocnemius and soleus muscle fibres
18
 that were persistent over the subsequent 3–10 min 
intervals investigated
15,16
. In contrast, ≥1.0 mM caffeine induced early [Ca2+]i peaks followed 
by reductions to persistently below-resting [Ca
2+
]i within 80-90 sec
16,17
. The latter was 
attributed to a slow RyR inactivation reducing channel open probabilities taking place over 
seconds. This property was previously demonstrated in sheep and rabbit skeletal muscle 
RyRs reconstituted in lipid bilayers under levels of steady [Ca
2+
]i that would initially produce 
RyR activation (~10-100 µM)
19
.  
The present experiments correspondingly investigated effects of 0.5 mM and 2.0 mM 
caffeine on INa in intact murine skeletal muscle using the loose-patch clamp approach. This 
employed relatively low-resistance seals (<2 MΩ) with an undisrupted surface membrane 
thus leaving intracellular, particularly [Ca
2+
]i homeostasis unperturbed. In contrast, 
conventional tight-patch seals often include the Ca
2+
-sequestrating ethylene glycol-
bis(βaminoethyl ether)-N,N,N',N'-tetraacetic acid (EGTA) in intracellular pipette solutions. 
In addition, the loose-patch pipettes could be re-used between patches, permitting sequential 
and multiple recordings from the same cell before and after pharmacological challenge. This 
permitted standardized comparisons between successive results with the same pipette 
20
. Test 
results were compared with effects of control challenges using the known specific RyR 
blocker dantrolene
21
 to identify caffeine effects specifically attributable to its direct RyR 
action. 
 
RESULTS 
 
Currents obtained using the double pulse protocol 
The experiments employed a loose-patch clamp preparation and recording layout fully 
described in the Materials and Methods section (Fig. 1). Voltage-dependences of Na
+
 current, 
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INa, including its activation and inactivation, were examined using a double test pulse 
protocol (Fig. 1D). In each sweep of the full protocol, the membrane was first held at resting 
membrane potential (RMP) for 5 ms. A hyperpolarising pre-pulse, duration 50 ms, imposed 
at times 5–55 ms from the beginning of the sweep to voltage V0 = (RMP–40) mV, first 
removed any residual INa inactivation at the RMP. This standardized the proportion of 
activatable Na
+ 
channels prior to application of the subsequent depolarising V1 pulse, itself of 
duration 10 ms, at time 55–65 ms.  
 
At early intervals immediately following solution change, a simplified protocol examined INa 
in individual patches. This averaged results from 5 sweeps of a pulse protocol imposing a 
single voltage step to a single voltage V1 at (RMP+80) mV between 55 and 80 ms. INa 
features at later time intervals following solution change were studied using the full 
procedure. This examined effects of a family of V1 amplitudes varied between sweeps in +5 
mV increments through test voltages between RMP and (RMP+80) mV. This elicited 
currents reflecting the voltage dependence of INa activation. A further V2 pulse was then made 
to a constant, depolarised voltage of (RMP+80) mV. This would activate all the Na
+
 channels 
within the patch not inactivated by the preceding V1 pulse. This made it possible to explore 
the voltage dependence of Na
+
 current inactivation. For each value of V1, currents from 10 
sweeps were averaged before examining the next value of V1. Each complete protocol applied 
to a single patch therefore involved collection of currents from 170 sweeps.  
 
Figure 1E exemplifies currents obtained by a single sweep at a single voltage, V1 = 
(RMP+35) mV following P/4 correction under control conditions. Downward, negative 
deflections denote inward while upward, positive deflections represent outward membrane 
currents. The V0 pulse typically yielded no currents. The V1 and associated V2 steps each 
elicited transient inward currents representing the opening and inactivation of Na
+
 channels. 
The magnitudes of their peaks, i1 and i2, were measured relative to the currents measured just 
before the respective V1 and V2 steps.   
 
Each patch was only subjected to a single application of the complete set of pulse protocols. 
This made differences between results arising from prolonged changes in the patch such as 
membrane blebbing unlikely
22
. Furthermore, following every set of sweeps a further 
bracketing protocol was then imposed using a single V1 step to RMP. The resulting average i2 
value from the succeeding V2 step was then compared with the i2 value obtained by the first 
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10 sweeps of the preceding test protocol, for which V1 was also RMP. Patch stability was 
confirmed, permitting further analysis, if the bracketing i2 value was within 10% of the test i2 
value. Thus, only patches with a stable seal, INa generation, and activation and inactivation 
characteristics were selected for further analysis.   
 
Early effects of caffeine on Na
+
 currents 
The initial experiments explored for alterations in INa at the earliest times (1-4 min) following 
introduction of caffeine. The simplified protocol employing a single V1 test voltage of 
(RMP+80) mV permitted prompt assessments of INa at times immediately following solution 
change. This made it additionally possible to explore the effects of using differing patch-
clamping protocols either excluding or permitting caffeine access to membrane beneath the 
patch seal. All these manoeuvres first obtained control currents in the absence of caffeine 
(Fig. 2(A-D)(i)). The INa records showed increasing followed by decaying phases, 
conforming to previously established expectations of a voltage-dependent activation followed 
by more gradual inactivation of INa.  In a first procedure, the patch pipette was then 
withdrawn, 0.5 mM caffeine was introduced, and the patch seal re-established 30 sec later. 
This procedure permitted caffeine access to membrane both beyond and within the patch seal, 
prior to further applications of the pulse procedures (Fig. 2A(i)). The challenge with 0.5 
caffeine then produced reductions in INa
 
from the first minute of exposure (Fig. 2A(ii)). 
A second procedure on a different patch employing a differing procedure yielded contrasting 
results. Following acquisition of control records (Fig. 2B(i)), 0.5 mM caffeine-containing 
extracellular solution was introduced whilst the pipette seal was maintained intact. Currents 
were similarly obtained at timed subsequent intervals. Here, the patch seal was accordingly 
continually maintained before, during and following introduction of caffeine-containing 
extracellular solution. This gave caffeine immediate access to membrane beyond but not 
within the patch seal. Challenge by 0.5 mM caffeine now produced little subsequent, early 
change in peak currents even with repeated INa determinations made at 1 min intervals 
between 1 to 4 minutes (Fig. 2B(ii)). In contrast, the effect of 0.5 mM caffeine in reducing INa 
could be finally restored in subsequent recordings made after lifting the patch pipette and 
restoring the patch seal 30 s later (Fig. 2B(iii)).  
Separate experiments using 2.0 mM caffeine challenge gave concordant, complementary, 
results. Relative to the initial recordings in the absence of caffeine (Fig. 2C(i)), 2.0 mM 
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caffeine initially produced a reduced INa, but this was rapidly succeeded by increased INa if 
the latter test recordings were made after lifting then restoring the patch seal (Fig. 2C(ii)). 
These effects were attenuated when the 2.0 mM caffeine was added then test recordings made 
whilst contrastingly maintaining an intact patch seal (Fig. 2D(i) and (ii)).  
These findings suggested that both 0.5 and 2 mM caffeine reduced INa
 
within the first minute 
of exposure. This reduction persisted over 1, 2 and 3 min with 0.5 mM caffeine, but was 
succeeded by a marked increase in INa with 2 mM caffeine. However, such effects required a 
direct access of the caffeine to the area of membrane beneath the patch pipette in which INa 
was recorded. The subsequent explorations of caffeine effects on INa using the full pulse 
procedure at the later times accordingly challenged with caffeine prior to formation of the 
patch seal.  
 
Effects on INa magnitudes of 0.5 mM caffeine challenge 
The INa recordings showed patterns that paralleled the previously reported contrasting [Ca
2+
]i 
changes produced by 0.5 and 2.0 mM caffeine concentrations. Fig. 3 illustrates current 
records from families of voltage steps at differing V1 between RMP and (RMP+80) mV under 
control conditions (A) and at different times following introduction of 0.5 mM caffeine (B). 
Initial rates of rise of current increased non-linearly with degree of depolarization elicited by 
the V1 steps. So did the peak INa which then reached a maximum at V1 ≈ (RMP+75) mV 
before decreasing with further depolarisation. The subsequent V2 steps yielded currents 
whose peak INa decreased with increasingly positive V1 consistent with prior voltage-
dependent channel inactivation reducing the proportion of remaining activatable Na
+
 
channels. The pulse protocols were repeated on different patches over successive time 
intervals following the introduction of caffeine. Figure 3B((i)-(iv)) illustrates typical families 
of traces obtained from 8, 20, 37 and 45 min following introduction of caffeine. Comparison 
of the successive sets of records suggested that peak INa initially showed marked, ~80%, 
reductions within the 10-minute interval following challenge (Fig. 3B(i)-(ii)). This was 
followed by a recovery which then returned INa to pre-treatment levels over a >40 min time-
course (Fig. 3B(iii)-(iv)).  
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Changes in the voltage dependence of INa resulting from 0.5 mM caffeine 
challenge 
Findings of this kind yielded INa current-voltage activation (I-V) and inactivation curves 
plotting dependences of peak INa on V1 in response to the respective V1 and V2 voltage steps. 
These are plotted for families of records obtained at different intervals following onset of 
caffeine challenge (Fig. 4). These curves demonstrated that compared to pre-treatment 
controls (Fig. 4A(i)), INa was reduced at 1-10, 11-25 and 26-40 min (Fig. 4A(ii)-(iv) 
respectively). However INa had recovered by the final (41-55 min) time interval (Fig. 4A(iv)). 
The maximum values of peak INa could be determined within the voltage range examined in 
the I-V curves obtained in the controls at 1-10 and 41-55, but not 11-25 and 26-40 min. 
Accordingly, the same determinations were made under control conditions and at 11-25, and 
26-40 minutes with a modified pulse protocol (Fig. 5) that explored an increased V1 range 
extending to (RMP+120) mV and using a V2 step to (RMP+100) mV. This encompassed the 
V1 at which maximum peak INa was observed, both under the control conditions (Fig. 5(i)) 
and at the selected times following addition of caffeine (Fig. 5(ii),(iii)). Together the I-V plots 
suggested that the greatest peak INa occurred with depolarisations to (RMP+105) mV at 11-25 
min and at (RMP+95) mV at 26-40 min respectively. 
 
Fig. 6A plots values of these parameters in successive patches with time following 
application of caffeine. Tables 1A and 2A list these parameters as means ± SEM from 
explorations grouped in successive time intervals as adopted in Fig. 3. This made it possible 
to test for statistically significant differences from the control findings obtained before 
addition of 0.5 mM caffeine. These demonstrated that within 1–10 min after adding caffeine, 
there was a sharp reduction in Imax. In addition, there was a negative shift in the V* value 
describing INa inactivation. In contrast, V* values for INa activation and k values for both 
activation and inactivation then remained unchanged. There then followed marked positive 
shifts in the V* of both INa activation and INa inactivation. The final INa recovery to 
pretreatment values, was then accompanied by more gradual negative shifts in the voltage 
dependence of both INa activation and INa inactivation, with control Imax, and V* values 
regained at 26 – 40 and 41–55 min respectively. These changes in Imax and V* contrasted with 
the constant k values through these manoeuvres. Furthermore, they were abolished, as 
described fully below, by dantrolene-mediated RyR block.   
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Changes in magnitude and voltage dependence of INa resulting from 2 mM 
caffeine challenge 
Caffeine challenge at a 2 mM concentration gave contrasting INa changes. Following the 
initially decreased peak INa within 2 min described above (Fig. 2C), the pattern assumed a 
transient increase in INa followed by its recovery to control levels. Fig. 7 shows families of INa 
records obtained using the full pulse protocol as in Fig. 3 at the different times subsequent to 
2.0 mM caffeine challenge. The current waveforms increased to a peak INa followed by an 
inactivating decline (Fig. 7A). However, the families of currents demonstrated markedly 
greater INa at 2–15 min following exposure to 2 mM caffeine, in contrast to the reduction in 
INa produced by 0.5 mM caffeine. INa then progressively declined to pre-treatment levels over 
the succeeding time intervals (Fig. 7B(i)-(iii)). Figure 8A plots the resulting I-V and 
inactivation curves obtained at different time intervals, from which it was possible to obtain 
Imax, V* and k values for the I-V and inactivation curves. Fig. 9 plots these values for 
successive patches with time following application of caffeine and Tables 3A and 4A 
summarise the statistical analysis of their means ± SEM from explorations in the successive 
time intervals, comparing these against the control pretreatment results. 
 
The INa amplitudes, Imax, increased threefold over the 2–15 min following addition of caffeine 
when compared to its control values (Compare Fig. 8A(i) and (ii)). Imax then recovered in 
subsequent intervals to regain pre-treatment values at 26-40 minutes (Fig. 8A(iii) and (iv)). 
There were delayed negative shifts in the V* of both INa activation and INa inactivation at 16-
25 min followed by smaller positive shifts at 26-40 min ((Fig. 9A(ii)); Tables 3A and 4A). 
Again, in common with findings using 0.5 mM caffeine, values of k showed relatively little 
change through these protocols.  
 
Effect of dantrolene on the INa responses to 0.5 and 2.0 mM caffeine 
 
The final sequence of experiments examined the effects of the specific RyR inhibitor 
dantrolene both by itself and on these divergent actions of 0.5 and 2.0 mM caffeine on INa 
using otherwise identical pulse protocols. Each experiment first obtained families of INa 
traces in the absence of all test agents in two successive patches studied within a first 10 min 
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interval. The bath solution was then substituted for one containing 10 µM dantrolene and 2 
further patches investigated within the next 10 minutes. The final INa records were then 
obtained after further replacing the bath solution with one containing both 0.5 or 2.0 mM 
caffeine and 10 µM dantrolene-containing solution. Patches were investigated using the same 
full pulse protocols as shown in Fig. 1.  
 
Including dantrolene alone slightly increased peak INa (Fig. 3C and 7C). Analysis of the I-V 
relationships (Fig. 4B and 8B) accordingly demonstrated small but significant increases in 
activation and inactivation Imax compared to controls, but no effect on activation and 
inactivation V* and k values (Tables 5 and 6).  
 
Simultaneous addition of dantrolene and 0.5 mM (Fig. 3C, D) or 2.0 mM caffeine (Fig. 7C, 
D) (Tables 1-4) resulted in currents whose magnitudes were similar to those obtained in the 
presence of dantrolene alone, at all the time intervals following the addition of caffeine. 
Dantrolene thus abrogated both the effects of 0.5 mM caffeine in producing transient 
decreases (Fig. 3D(i)-(iv)), and the effects of 2 mM caffeine in producing transient increases 
in INa (Fig. 7D(i)-(iii)). In parallel with the previous test experiments, I-V and inactivation 
relationships were plotted for fibres studied in the presence of dantrolene and either 0.5 mM 
(Fig. 4B) or 2.0 mM caffeine (Fig. 8B) through the same time intervals as those used after 
challenge with 0.5 mM or 2.0 mM caffeine alone, respectively.  
 
Figures 6B and 9B plot the resulting Imax, V* and k values for the I-V and inactivation curves 
for successive patches with time before, and following addition of either 0.5 (Fig. 6B) or 2 
mM caffeine (Fig. 9B) in successive individual patches exposed to dantrolene. None of these 
parameters showed the contrasting pattern of time-dependent changes in activation and 
inactivation parameters shown with 0.5 and 2 mM caffeine challenge in the absence of 
dantrolene. Tables 1-4 summarise the statistical analysis of their means ± SEM from 
explorations in the successive time intervals comparing these (B) against the control 
pretreatment results (A). In both analyses the activation and inactivation Imax, V
*
 and k values 
were respectively statistically indistinguishable from those obtained under dantrolene 
challenge alone when caffeine was absent. Again values of k remained constant through the 
experiments.  
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Neither challenge by dantrolene, nor that by caffeine, whether by itself or in combination 
with dantrolene, noticeably affected INa kinetics. When quantified by times to peak current at 
voltages yielding maximum INa in the I-V curves, control experimental groups subsequently 
used to test effects of dantrolene alone, or 0.5 or 2 mM caffeine in the absence of or 
following further dantrolene challenge, gave times of 0.49 ± 0.010, 0.48 ± 0.0093 and 0.50 ± 
0.012 ms respectively. Dunnett multiple comparison tests demonstrated that none of the 
subsequent interventions produced significantly alterations for all the time intervals assessed 
in Tables 1-4 (all P>>0.05).   
 
These control experiments thus demonstrate that (a) the RyR inhibitor dantrolene abrogated 
the contrasting actions of either 0.5 mM or 2.0 mM caffeine in transiently decreasing or 
increasing INa with accompanying changes in V* to previously established altered RyR-
mediated changes in [Ca
2+
]. (b) Their demonstration of an increased INa in the presence of 
dantrolene alone complements the demonstrations of increased INa produced by 2 mM 
caffeine in suggesting some background inhibition of INa at even background resting [Ca
2+
]i.   
 
DISCUSSION 
 
The present experiments explored for the existence of physiologically effective feedback 
loops between ryanodine receptor (RyR) activation by tubular depolarisation and Nav1.4 
channel function that would thereby modify surface membrane excitability in skeletal muscle 
in vivo. This mechanism would complement feedforward, excitation-contraction-coupling, 
processes by which Nav1.4-mediated surface membrane depolarisation triggers RyR-
mediated release of intracellularly stored sarcoplasmic reticular (SR) Ca
2+
. Feedback 
alterations in Nav1.4 availability and/or voltage sensitivity are potentially physiologically 
important particularly under conditions of intense and prolonged muscle activation including 
tetanic stimulation and metabolic exhaustion. The latter changes could compromise SR Ca
2+
-
ATPase activity through ATP depletion, thereby elevating [Ca
2+
]i. Any consequent effects of 
Ca
2+
 on Nav1.4 function would complement its other actions promoting slow RyR 
inactivation
19
 and increasing sarcolemmal Ca
2+
-activated large conductance K
+
 channel 
(KCa1.1) conductance in downregulating excitation-contraction coupling
23
. Such feedback 
mechanisms would also bear on clinical conditions affecting skeletal muscle excitability. K
+
-
aggravated myotonia is associated with slowed INa kinetics and impaired INa inactivation that 
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accompany Nav1.4 mutations in its EF-hand-like domain
24
. Other genetic, K
+
 and cold-
aggravated myotonias are associated with reduced Ca
2+
-dependent Na
+
 channel inhibition 
similarly attributed to Nav1.4 mutations
6
. Finally, the weakness observed in dystrophic 
muscle is associated with elevated [Ca
2+
]i
25
.   
 
The experiments here examined effects of direct pharmacological manipulation of RyR-
mediated SR Ca
2+
 release by the RyR agonist caffeine
14
 on both Nav1.4 channel availability 
and its voltage-dependent activation and inactivation properties in intact skeletal myocytes. 
They utilised previously established contrasting effects of different applied caffeine 
concentrations on spectrofluometrically measured resting [Ca
2+
]i
15,16
. Low concentrations of 
caffeine (0.5mM) then increased [Ca
2+
]i persistently over the subsequent 3–10 min recording 
intervals in isolated rabbit skeletal SR or murine skeletal muscle fibre preparations
15
. In 
contrast, ≥1.0 mM caffeine induced early [Ca2+]i peaks rapidly followed by [Ca
2+
]i decreases 
below even resting-levels within 80-90 sec
16,17
.  
 
Here, Na
+
 currents, INa were measured in intact mammalian gastrocnemius skeletal muscle 
using the loose patch clamp technique. This avoided membrane disruption and perturbations 
of [Ca
2+
]i homeostasis inherent in other experimental measurement procedures involving 
conventional cell-attached patch clamp studies, which additionally often include the Ca
2+
-
sequestrating EGTA in the pipette solutions. Furthermore, the latter can require study of 
isolated or cultured cells with enzymatically treated membranes as opposed to the intact in 
situ skeletal myocytes examined here. The loose-patch configuration also permitted 
sequential and multiple recordings with the same standardized pipette in successive patches 
before and after pharmacological challenge as required in the present experiments
26
. The 
features of the resulting INa concurred with those obtained on earlier occasions
26
 and with 
other voltage clamp methods applied to mammalian skeletal muscle
27
. The magnitude, 
voltage-dependence and quantified activation (current-voltage, I-V) and inactivation 
properties of INa were compared at different times following introducing caffeine. Further 
experiments blocking these effects with further applications of the specific RyR inhibitor 
dantrolene attributed the observed changes specifically to altered RyR-mediated SR Ca
2+
 
release. 
 
The observed contrasting alterations in INa closely paralleled the previously reported [Ca
2+
]i 
changes following caffeine challenge. Thus, INa was reduced early (1-2 min) following either 
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0.5 or 2 mM caffeine challenge. This effect was abrogated by reducing access of caffeine to 
tubular and therefore tubular-sarcoplasmic reticular triad regions in which RyRs are 
concentrated, in regions within the patch from which the recordings were obtained. The latter 
was accomplished by establishing patch seals before rather than after introduction of caffeine 
to the extracellular space. This would alter direct access of caffeine over a surface membrane 
area close to the 30 μm2 cross sectional area of the electrode tip in contact with the membrane 
within which INa was recorded. 
 
Subsequent recordings following the 0.5 and 2 mM caffeine challenge obtained by identical 
pulse protocols respectively demonstrated contrasting increases and decreases in peak INa 
followed by their recovery to pretreatment levels. These findings corroborate and extend 
previous independent reports that INa was reduced by increased RyR activity following 8-CPT 
induced Epac pathway activation
13
. The INa changes were quantified by systematically 
exploring a consistent range of V1 test voltages thereby deriving families of INa records. These 
in turn yielded activation, I-V, and inactivation curves giving Imax, V* and k values. These 
respectively quantified total available INa and the position and steepness of their voltage 
dependences. Sustained reductions in Imax induced by 0.5 mM caffeine paralleled the 
sustained [Ca
2+
]i increases previously reported following caffeine mediated activation of 
RyR-mediated SR Ca
2+
 release
15
. The increased INa observed in the presence of 2 mM 
caffeine similarly paralleled reported contrastingly decreased [Ca
2+
]i attributed to slow RyR 
inactivation
16,17
. The latter findings further suggested significant inhibition of INa by even 
normal background [Ca
2+
]i.  
 
These alterations in total available INa were accompanied by time-dependent changes in 
properties of the I-V and inactivation curves. With 0.5 mM caffeine challenge, the initial 
decreases in INa were accompanied by negative shifts in inactivation V* over 1-10 min. This 
was followed, over 11-25 min, by positive shifts in both INa activation and INa inactivation V*. 
The final INa recovery to pretreatment values between 26-55 min was accompanied by 
opposite, negative, shifts in activation and inactivation V*. With 2 mM caffeine challenge, 
the contrasting, declining phases of the transient INa increases accompanied delayed transient 
negative shifts in both activation and inactivation V*. In contrast, values of k of either 
activation or inactivation little changed throughout these protocols.  
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Finally, the effects of the specific RyR inhibitor dantrolene were investigated both by itself 
and in combination with identical caffeine concentrations and pulse protocols. Dantrolene 
specifically stabilises RyR closed states by selectively decreasing Ca
2+
 affinities of RyR 
activation sites
21
. Previous reports had demonstrated that it inhibited caffeine-induced 
increments in mammalian SR Ca
2+
 permeability
28
 and caffeine-induced contractures in 
murine diaphragm muscle
29
.  
 
In the present experiments dantrolene abrogated all the effects of either 0.5 or 2 mM caffeine, 
whether on Imax, or activation or inactivation INa or V*. In contrast, dantrolene by itself 
produced only small increases in Imax without affecting activation and inactivation, V* and k 
values. Together with the increased INa produced by 2 mM caffeine this latter finding 
suggests that [Ca
2+
]i exerts significantly inhibits INa even at background RyR activity. These 
explorations using dantrolene thus trace all the present actions of caffeine on INa specifically 
to its effects on RyR-mediated SR Ca
2+
 release. 
 
These findings together demonstrate and characterise RyR-Nav1.4 feedback phenomena 
complementing their established feedforward interactions underlying excitation contraction 
coupling (Fig. 10A). The observed contrasting effects of caffeine challenge on Imax and V* 
combined with previously reported [Ca
2+
]i changes under similar experimental conditions
15–17
 
were incompatible with straightforward combined negative shifts in Na
+
 channel activation 
and inactivation V* resulting from simple screening effects arising from an increased [Ca
2+
]i 
30,31
. However, they directly correlate with previous in vitro biochemical and biophysical 
reports on skeletal muscle Nav1.4 and RyR. They establish for these a physiological context, 
possibly occurring within a common microdomain, in working muscle, as opposed to in vitro 
systems for the first time.  
 
First, the early INa reductions with 0.5 and 2 mM caffeine, persistent with 0.5 mM caffeine, 
were consistent with the reported effects of either direct Ca
2+
-binding to a Nav1.4 EF hand 
site or indirect Ca
2+
 binding to Nav1.4 via its binding to CaM in reducing INa (Fig. 10C). 
Secondly, the accompanying early negative V* shifts 1-10 min following 0.5 mM caffeine 
challenge paralleled reported negative shifts in voltage-dependent inactivation produced by 
the indirect Ca
2+
 binding process
2,6–8
. This was selective for Nav1.4 as opposed to Nav1.5, 
reflecting Nav1.4 lacking the CaM N-lobe binding site present in Nav1.5
1
. Thirdly, the 
subsequent (11-25 min) positive shifts in INa activation and inactivation V* directly paralleled 
15 
 
reported reductions in FKPB12 binding affinity for RyR following RyR activation. A 
increased free [FKBP12]i would then accompany the resulting SR Ca
2+
 release elevating 
[Ca
2+
]i. in intact fibres
9,10
; FKBP12 is known to positively shift V* activation and inactivation 
in Nav1.5
11
, thought closely homologous to Nav1.4
4
. This action is probably indirect and 
delayed: co-immunoprecipitation assays appeared to exclude direct FKBP12–Nav1.5 
interactions
11
. Fourthly, negative shifts in both INa activation and inactivation V* values 
eventually accompanied the reductions in INa and recoveries from INa elevation, 26-55 or 16-
40 min following 0.5 and 2.0 mM caffeine challenge respectively. These were compatible 
with a subsequent, previously reported, slow RyR inactivation
19
. This would reduce RyR 
open channel probabilities and Ca
2+
 release whilst permitting continued SR Ca
2+
 re-uptake 
and possible surface membrane Ca
2+
 expulsion by Na
+
/Ca
2+
 exchange
32,33
. These would 
reverse the increases in [Ca
2+
]i and [FKBP12]i
19
 (Fig. 10D). Finally, the effects of the RyR 
inhibitor dantrolene (Fig. 10B) abrogating all these contrasting reductions and increases in INa 
associated with different caffeine concentrations through the identical pulse protocols 
associated all these findings with feedback effects arising specifically from the RyR.  
 
MATERIALS & METHODS 
Experiments were performed under the Animals (Scientific Procedures) Act 1986 
Amendment Regulations 2012 following ethical review by the University of Cambridge 
Animal Welfare and Ethical Review Body (AWERB). C57BL6 WT mice aged 3-6 months 
were used in all experiments. Mice were housed at a stable temperature of 21°C in a licensed 
facility, fed sterile rodent chow (RM3 Maintenance Diet; SDS, Witham, United Kingdom) 
and subjected to 12-hour light/dark cycles with free access to water, bedding and 
environmental stimuli. Krebs–Henseleit (KH) solution (mmol/L: NaCl, 130; KCl, 4.0; 
HEPES, 1.2; MgCl2, 1.0; CaCl2, 1.8; glucose, 10; and Na-pyruvate, 2.0; pH adjusted to 7.4) 
was used in all experiments. Chemical agents were purchased from Sigma-Aldrich (Poole, 
UK) unless otherwise stated. The following variants of the basic KH solution containing 
caffeine and/or dantrolene including 0.1% dimethyl sulfoxide vehicle were prepared and used 
in experiments: (1) KH + 0.5 mM caffeine, (2) KH + 2.0 mM caffeine, (3) KH + 10 µM 
dantrolene, (4) KH + 10 µM dantrolene + 0.5 mM caffeine, and (5) KH + 10 µM dantrolene 
+ 2.0 mM caffeine. Solutions were filtered to remove particles greater than 10 μm in diameter 
with standard filtration paper (Millipore, Bedford, MA, USA).  
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Mice were killed by cervical dislocation by Home Office-licensed personnel in accordance 
with Schedule 1 of The Animals (Scientific Procedures) Act 1986. The gastrocnemius and 
soleus muscles were then immediately isolated, with the distal (Achilles) tendon secured by a 
knot to a ligature and the proximal tendon still attached to its bony origin. Overlying 
connective tissue was excised to allow access to the myocyte surface. The isolated muscles 
were then immediately placed in a Sylgard-bottomed experimental bath containing KH 
solution with the soleus muscle facing down maximizing electrode access to gastrocnemius 
fibres. Experiments were carried out at stable temperatures around 20 ºC. The muscle was 
secured in a taut and fixed position by pinning down the bony origin and the ligature with A1 
insect pins (Fig. 1A). 
Loose patch clamp pipettes were pulled from borosilicate glass capillaries (GC150‐10; 
Harvard Apparatus, Cambridge, UK) using a Brown–Flaming microelectrode puller (Model 
P‐97; Sutter Instrument Co. Novato, CA). They were mounted under a microscope with ×250 
magnification with a calibrated eyepiece graticule, and a small indentation made on one side 
of the pipette using a diamond knife. A transverse force was then applied distal to the 
indentation, giving a fracture perpendicular to the long axis of the pipette. Squarely-broken 
tips were then fire‐polished under visual guidance at ×400 magnification using an 
electrically-heated nichrome filament to smooth the edges of the tip. The internal diameters 
of the pipettes were measured under ×1000 magnification. Pipettes of internal tip diameters 
between 28-38 µm were used in the experiments. Such loose patch recordings thus provide a 
complete representation of the properties of both surface and tubular membrane directly 
beneath these seals. Finally, the pipettes were bent at about 1 mm from the tip to make a 45° 
angle with the pipette’s long axis. This allowed the tips to contact the muscle surface at 90º 
when mounted at an angle of 45º below the horizontal on the recording amplifier head stage 
(Fig. 1B). The pipettes were mounted onto a pipette holder with an Ag/AgCl electrode held 
within the inside of the pipette. The distal half of the pipette was filled with solution from the 
bath, using suction provided by a syringe via an air-filled connection to the pipette holder. 
The bath was actively grounded at reference potential, using an Ag/AgCl electrode. These 
Ag/AgCl electrodes maintained electrical connection between the organ bath and pipette with 
the electronic circuit. 
The pipette was lowered onto the gastrocnemius muscle membrane surface and gentle suction 
applied to allow seal formation around the resulting membrane patch. The central regions of 
the muscle (crosshatched region in scheme shown in Fig. 1A) were targeted for each 
17 
 
experiment as this region was the most horizontal, permitting optimal (~90º) contact between 
pipette tip and muscle. The loose patch clamp configuration clamps the voltage on the 
extracellular side of the membrane within the pipette seal. Therefore, positive and negative 
potentials applied within the pipette respectively hyperpolarise and depolarise the membrane 
potential of the patch relative to the cell resting membrane potential (RMP). In this report, the 
signs of the voltage steps are inverted and membrane potentials expressed relative to RMP, a 
convention adopted by previous papers using this technique
12,13,20,26
. The Ag/AgCl electrode 
within the pipette both measured the intra-pipette potential relative to the ground reference 
potential of the bath and passed the clamp current. 
Fig. 1C shows the equivalent circuit of a typical patch. The loose patch technique involves a 
relatively low seal resistance (typically <2 MΩ). This ohmic leakage and series resistance 
error [(seal resistance + patch resistance) and pipette resistance], along with additional pipette 
capacitance currents were largely corrected by a bridge circuit within the loose patch clamp 
amplifier
26
. The remaining linear leakage and capacitive currents were corrected using a P/4 
protocol in which the test steps were followed by four control voltage steps a quarter the 
amplitude and of opposite signs to the test step. These were of a sign and/or amplitude that 
did not activate the voltage conductances, hence only eliciting leak currents. These responses 
were measured, summed and subtracted from the current values obtained from the original 
test step within the loose patch clamp
26
. 
An IBM-compatible computer connected to the loose patch clamp amplifier, which was 
connected to the headstage that held the recording pipette was used to deliver voltage clamp 
steps relative to the RMP. Study of each patch commenced with strongly depolarising +80 
mV, 15 ms pulses in order to confirm the presence of ion channels. Only patches showing 
clear, resolvable inward currents with kinetics characteristic of voltage-gated Na
+
 channels 
were investigated with the full set of pulse protocols. The patch clamp currents were sampled 
by the computer at a 50 kHz digital sampling rate and filtered with a DC-10 kHz bandwidth, 
using a 10 kHz Bessel low pass filter.  
Experiments were initially performed with the muscle preparation immersed in control KH 
solution. Around 2–3 different patches were investigated using the complete set of pulses 
within 20 minutes after transferring the muscle preparation into the bath. Only muscles that 
gave stable control results were further studied in the presence of pharmacological challenge. 
For each pharmacological condition, data from patches collected from at least 3 muscle 
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preparations were used. To achieve conditions comparable to previous studies on [Ca
2+
]i, the 
bathing solution was then rapidly replaced with KH solution containing either 0.5 mM and 
2.0 mM caffeine. The resulting effects on Na
+
 current amplitude, and activation and 
inactivation characteristics were then examined at increasing times from a sequence of 
different patches following onset of caffeine challenge.   Averaged currents from the 10 
sweeps obtained for each pulse voltage within the experimental protocol were then 
normalised to the pipette tip cross-sectional area to give current densities, using the formula 
relating current density (in pA/µm
2
), measured current (in nA) and pipette diameter (in µm): 
Current density (pA/µm
2
) = {measured current (nA) × 4000}/{π × [pipette diameter (µm)]2} 
The resulting peak I1 and I2 current densities obtained from the V1 and V2 steps in the double 
pulse protocols generated activation and inactivation current-voltage (I-V) curves, 
respectively, for each patch. The rising phase of the activation I-V curve for each patch was 
fitted to a two-state Boltzmann function relating the peak current density for any V1 excursion 
(I1) to its maximum value (Imax), the voltage at half maximal peak current (V*), the excursion 
corresponding to the V1 step (V) and the steepness factor (k):  I1= Imax/[1+exp{(V*-V)/k}]). 
The inactivation I-V curves were fitted to a similar Boltzmann function relating the peak 
current density I2 for the V2 step following any given V1 excursion to its maximum value 
(Imax), the voltage at half maximal current (V
*
), the excursion of the V1 step (V) and a 
steepness factor (k): I2= Imax(1-1/[1+exp{(V*-V)/k}]).  
 
Successive families of ionic currents revealed alterations in current characteristics with time 
following caffeine challenge. These are represented by displaying currents, current-voltage 
curves and computed values of Imax, V
*
 and k as obtained from each patch averaged to give 
means ± SEM for currents obtained within successive time intervals following introduction of 
pharmacological agents. Curve fitting procedures of the I-V curves used fitting algorithms in 
the open source programme SciDAVis (Version 1.25-mac). Derived parameters obtained 
under different conditions were tested for significant differences to a P<0.05 significance 
level by ANOVA with a post-hoc Dunnett’s test. 
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Table 1. Mean Imax, V
*
 and k values of activation I-V curves at increasing time intervals following 
addition of 0.5 mM caffeine in the presence of (A) 0 μM dantrolene and (B) 10 μM dantrolene.  P values 
indicate significance of differences compared to control values. * denotes a significant difference 
compared to controls where P<0.05 
Time after 
adding caffeine 
   (min) 
Imax, mean ± SEM (n- 
value), pA/µm
2
; 
p-value 
V
*
, mean ± SEM (n 
-value), mV; 
p-value 
k, mean ± SEM (n- 
value), mV; 
p-value 
(A) Experiments performed with 0.5 mM caffeine, 0 μM dantrolene 
  Control 27.15± 0.971 (n=13) 50.47 ± 0.721 (n=13) 6.720 ± 0.412 (n=13) 
  1 - 10 5.14 ± 1.448 (n=6)* 
P < 0.0001 
50.75 ± 0.749 (n=6) 
P = 0.8182 
7.90 ± 0.455 (n=6) 
P = 0.1015 
  11 - 25 11.65 ± 1.964 (n=5)* 
P < 0.0001 
73.16 ± 2.099 (n=5)* 
P < 0.0001 
9.02 ± 0.286 (n=5) 
P = 0.0546 
  26-40 15.30 ± 0.875 (n=5)* 
P < 0.0001 
57.33 ± 2.115 (n=5)* 
P = 0.0011 
8.07 ± 0.274 (n=5) 
P = 0.0709 
  41-55 26.52 ± 1.970 (n=6) 
P = 0.7466 
47.45 ± 1.372 (n=6)* 
P = 0.0461 
6.72 ± 0.346 (n=6) 
P = 0.9974 
 
(B) Experiments performed with 0.5 mM caffeine, 10 μM dantrolene 
Dantrolene alone 31.80 ± 1.086 (n=8) 51.32 ± 0.703 (n=8) 6.55 ± 0.330 (n=8) 
1 - 10 31.92 ± 0.516 (n=5) 
P = 0.9322 
51.70 ± 1.076 (n=5) 
P = 0.7648 
6.10 ± 0.297 (n=5) 
P = 0.3714 
11 - 25 31.77 ± 0.467 (n=5) 
P = 0.9831 
50.80 ± 0.720 (n=5) 
P = 0.6365 
6.86 ± 0.235 (n=5) 
P = 0.5119 
26-40 31.91 ± 0.448 (n=5) 
P = 0.9401 
52.08 ± 1.268 (n=5) 
P = 0.5802 
6.47 ± 0.359 (n=5) 
P = 0.8808 
41-55 31.27 ± 1.019 (n=5) 
P = 0.7481 
51.80 ± 0.797 (n=5) 
P = 0.668 
6.77 ± 0.112 (n=5) 
P = 0.6148 
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Table 2. Mean Imax, V
*
 and k values of inactivation I-V curves at increasing time intervals following 
addition of 0.5 mM caffeine in the presence of (A) 0 μM dantrolene and (B) 10 μM dantrolene.  P values 
indicate significance of differences compared to control values. * denotes a significant difference 
compared to controls where P<0.05 
Time after 
adding caffeine 
(min) 
Imax, mean ± SEM (n- 
value), pA/µm
2
; 
p-value 
V
*
, mean ± SEM (n 
-value), mV; 
p-value 
k, mean ± SEM (n- 
value), mV; 
p-value 
(A) Experiments performed with 0.5 mM caffeine, 0 μM dantrolene 
  Control 26.24 ± 1.245 (n=13) 30.22 ± 0.364 (n=13) 9.15 ± 0.217 (n=13) 
  1 - 10 4.50 ± 1.202 (n=6)* 
P < 0.0001 
22.27 ± 0.399 (n=6)* 
P < 0.0001 
9.00 ± 0.733 (n=6) 
P = 0.8105 
  11 - 25 11.33 ± 1.959 (n=5)* 
P < 0.0001 
40.68 ± 1.843 (n=5)* 
P < 0.0001 
9.28 ± 0.516 (n=5) 
P = 0.7797 
 
  26-40 16.09 ± 0.896 (n=5)* 
P = 0.0002 
26.71 ± 0.730 (n=5)* 
P = 0.0002 
9.31 ± 0.563 (n=5) 
P = 0.7361 
  41-55 24.90 ± 1.614 (n=6) 
P = 0.5421 
24.03 ± 1.526 (n=6)* 
P < 0.0001 
9.00 ± 0.344 (n=6) 
P = 0.7255 
 
(B) Experiments performed with 0.5 mM caffeine, 10 μM dantrolene 
Dantrolene 
alone 
32.17 ± 1.225 (n=8) 29.71 ± 0.555 (n=8) 9.62 ± 0.258 (n=8) 
1 - 10 32.00 ± 1.535 (n=5) 
P = 0.9305 
27.97 ± 0.651 (n=5) 
P = 0.071 
9.77 ± 0.358 (n=5) 
P = 0.7351 
11 - 25 33.05 ± 0.913 (n=5) 
P = 0.6227 
30.38 ± 0.630 (n=5) 
P = 0.4549 
9.63 ± 0.286 (n=5) 
P = 0.9975 
 
26-40 32.55 ± 0.528 (n=5) 
P = 0.8232 
28.68 ± 1.154 (n=5) 
P = 0.3855 
8.48 ± 0.320 (n=5) 
P = 0.187 
41-55 32.52 ± 1.213 (n=5) 
P = 0.8541 
30.11 ± 1.056 (n=5) 
P = 0.7191 
10.12 ± 0.538 (n=5) 
P = 0.3697 
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Table 3. Mean Imax, V
*
 and k values of activation I-V curves at particular time intervals after addition of 
2 mM caffeine in the presence of (A) 0 μM dantrolene and (B) 10 μM dantrolene. P values indicate 
significance of differences compared to control values. * denotes a significant difference compared to 
controls where P<0.05 
 
Time after 
adding caffeine 
(min) 
Imax, mean ± SEM (n- 
value),  pA/µm
2
; 
p-value 
V
*
, Mean ± SEM (n 
-value), mV; p-value 
k, mean ± SEM (n- 
value), mV; p-value  
(A) Experiments performed with 2 mM caffeine, 0 μM dantrolene 
Control 26.87 ± 1.346 (n=9) 51.01 ± 0.839 (n=9) 6.71 ± 0.518 (n=9) 
2 - 15 75.56 ± 9.026 (n=7)* 
P < 0.0001 
49.99 ± 0.568 (n=7) 
P = 0.3577 
5.35 ± 0.130 (n=7) 
P = 0.0507 
16 - 25 41.07 ± 4.714 (n=4)* 
P = 0.0023 
45.70 ± 1.711 (n=4)* 
P = 0.009 
5.85 ± 0.622 (n=4) 
P = 0.3531 
26-40 27.18 ± 1.844 (n=5) 
P = 0.8952 
47.37 ± 1.087 (n=5)* 
P = 0.0223 
6.49 ± 0.159 (n=5) 
P = 0.7647 
    
(B) Experiments performed with 2 mM caffeine, 10 μM dantrolene 
Dantrolene alone 31.80 ± 1.086 (n=8) 51.32 ± 0.703 (n=8) 6.55 ± 0.330 (n=8) 
1 - 15 31.14 ± 0.985 (n=6) 
P = 0.6755 
51.20 ± 0.643 (n=6) 
P = 0.9072 
6.31 ± 0.385 (n=6) 
P = 0.6494 
16 - 25 32.21 ± 1.186 (n=4) 
P = 0.8186 
51.94 ± 1.234 (n=4) 
P = 0.6483 
6.33 ± 0.374 (n=4) 
P = 0.6954 
26-40 31.17 ± 1.199 (n=5) 
P = 0.7132 
52.18 ± 0.650 (n=5) 
P = 0.4217 
6.02 ± 0.185 (n=5) 
P = 0.2633 
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Table 4. Mean Imax, V
*
 and k values of inactivation I-V curves at particular time intervals after addition 
of 2 mM caffeine in the presence of (A) 0 μM dantrolene and (B) 10 μM dantrolene. P values indicate 
significance of differences compared to control values. * denotes a significant difference compared to 
controls where P<0.05 
 
Time after adding 
caffeine 
(min) 
Imax, mean ± SEM (n- 
value),  pA/µm
2
; 
p-value 
V
*
, Mean ± SEM (n 
-value), mV; p-value 
k, mean ± SEM (n- 
value), mV; p-value  
(A) Experiments performed with 2 mM caffeine, 0 μM dantrolene 
Control 25.79 ± 1.713 (n=9) 30.03 ± 0.343 (n=9) 9.00 ± 0.269 (n=9) 
2 - 15 75.24 ± 7.502 (n=7)* 
P < 0.0001 
30.22 ± 0.507 (n=7) 
P = 0.7513 
8.39 ± 0.282 (n=7) 
P = 0.1422 
16 - 25 43.01 ± 5.505 (n=4)* 
P = 0.0022 
24.45 ± 0.437 (n=4)* 
P < 0.0001 
9.06 ± 0.605 (n=4) 
P = 0.9101 
26-40 26.40 ± 1.579 (n=5) 
P = 0.8169 
27.40 ± 1.458 (n=5)* 
P = 0.0411 
7.62 ± 0.398 (n=5) 
P = 0.0719 
    
(B) Experiments performed with 2 mM caffeine, 10 μM dantrolene 
Dantrolene alone 32.17 ± 1.225 (n=8) 29.71 ± 0.555 (n=8) 9.62 ± 0.258 (n=8) 
1 - 15 31.43 ± 0.786 (n=6) 
P = 0.6476 
30.43 ± 0.755 (n=6) 
P = 0.4431 
9.05 ± 0.362 (n=6) 
P = 0.2069 
16 - 25 32.48 ± 1.056 (n=4) 
P = 0.8756 
28.44 ± 0.925 (n=4) 
P = 0.238 
9.20 ± 0.165 (n=4) 
P = 0.3059 
26-40 32.38 ± 0.595 (n=5) 
P = 0.9029 
29.06 ± 0.811 (n=5) 
P = 0.509 
9.19 ± 0.393 (n=5) 
P = 0.358 
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Table 5. Mean Imax, V
*
 and k values of activation I-V curves before and after addition of 10 μM 
dantrolene. P values indicate significance of differences compared to control values. * denotes a 
significant difference compared to controls where P<0.05 
Condition Imax, mean ± SEM (n- 
value), pA/µm
2
; 
p-value 
V*, mean ± SEM (n 
-value), mV; 
p-value 
k, mean ± SEM (n- 
value), mV; 
p-value 
Control 27.67 ± 0.881 (n=8) 51.39 ± 0.528 (n=8) 5.92 ± 0.221 (n=8) 
Dantrolene 31.80 ± 1.086 (n=8)* 
P = 0.0105 
51.32 ± 0.703 (n=8) 
P = 0.9346 
6.55 ± 0.330 (n=8) 
P = 0.1372 
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FIGURE LEGENDS 
Figure 1. (A) Plan view of the muscle preparation after being pinned down at both ends in the bath. 
The soleus muscle (in grey) is overlaid by gastrocnemius. The shaded box in the centre represents the 
region of gastrocnemius fibres used for patch clamping.  
(B) Loose patch clamp experiment: Muscle preparation pinned down in KH solution. Pipette mounted 
at 45º to allow 90º contact of the bent tip with the fibre surface. The pipette is connected to a suction 
syringe
13
.  
(C) Equivalent circuit of loose patch clamp electrode on muscle membrane. Solution in the pipette 
clamped at Vpip. The voltage error arising from the flow of currents through the patch resistance 
(Rpatch) and the cell resistance (Rcell), along with the pipette resistance (Rpip) corrected mainly using a 
bridge circuit in the loose patch clamp amplifier
13
. 
(D) Complete set of pulse protocols carried out on a patch being investigated. This double test pulse 
protocol first superimposed a –40 mV hyperpolarising pre-pulse, lasting 50 ms, on the resting 
potential, RMP. This was followed by a depolarising V1 pulse varying in amplitude to test voltages 
between RMP and (RMP+80) mV in +5 mV increments. This was followed by a V2 pulse to a 
strongly depolarised potential of (RMP+80) mV.  
(E) The corresponding current trace during a single sweep in the protocol under control conditions 
where V1 = (RMP+35) mV, following P/4 protocol correction, giving peak currents I1 and I2. 
 
Figure 2. Results of simple pulse protocols to examine INa at early times following caffeine challenge 
using two experimental procedures. Following obtaining control records prior to caffeine challenge 
(A-D) panel (i), in (A), the patch electrode was withdrawn prior to introduction of 0.5 mM caffeine, 
and then restored prior to imposition of test steps (ii) in the following 1-3 min.  In (B) the patch seal 
Table 6. Mean Imax, V
*
 and k values of inactivation I-V curves before and after addition of 10 μM 
dantrolene. P values indicate significance of differences compared to control values. * denotes a 
significant difference compared to controls where P<0.05 
Condition Imax, mean ± SEM (n- 
value), pA/µm
2
; 
p-value 
V*, mean ± SEM (n 
-value), mV; 
p-value 
k, mean ± SEM (n- 
value), mV; 
p-value 
Control 27.66 ± 1.075 (n=8) 29.64 ± 0.5001 (n=8) 8.824 ± 0.4387 (n=8) 
Dantrolene 32.17 ± 1.225 (n=8)* 
P = 0.0151 
29.71 ± 0.5547 (n=8) 
P = 0.9321 
9.623 ± 0.2582 (n=8) 
P = 0.1386 
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was maintained before, during and following introduction of 0.5 mM caffeine through imposition of 
the test steps (ii). The latter procedure was repeated following pipette withdrawal and restoration of 
the patch seal (iii). (C) and (D) adopted identical respective procedures as (A) and (B) using a 2 mM 
caffeine concentration.  
Figure 3. Families of normalized current traces obtained from the double pulse protocol in response 
to caffeine challenge at a concentration of 0.5 mM in the absence (A, B) or presence (C, D) of 10 μM 
dantrolene. (A, C) Control traces obtained in KH solution, prior to caffeine challenge in the absence 
(A) or presence of dantrolene (C). (B, D) Families of records obtained at successive (i) 7-8 min, (ii) 
20-21 min, (iii) 35-37 min and (iv) 45-46 min intervals after addition of 0.5 mM caffeine-containing 
KH solution into the bath in the absence (B) or presence of dantrolene (D).  
Figure 4. Activation (left panels) and inactivation I-V curves (right panels of each pair) (mean of I1 or 
I2 ± standard error of mean (SEM) against each V1 excursion) in response to caffeine challenge at a 
concentration of 0.5 mM in the absence (A) or the presence (B) of 10 μM dantrolene. Experiments 
first obtained families of INa records before addition of caffeine in (A(i)), (B(i)). Families of INa 
records then obtained in intervals (ii) 1-10 minutes, (iii) 11-25 minutes (iv) 26-40 minutes and (v) 41-
55 min intervals after adding 0.5 mM caffeine. 
Figure 5. Activation and inactivation I-V curves (mean of I1 or I2 ± standard error of mean (SEM) 
against each V1 excursion) for the (i) control condition prior to addition of caffeine, and  (ii), 11-25 
minutes and (iii) 26-40 minutes after addition of 0.5 mM caffeine using an expanded range of V1 in 
the absence of dantrolene.    
Figure 6. Alterations in (i) Imax, (ii) V* and (iii) k derived from current-voltage (I-V) activation and 
inactivation curves  followed from successive patches studied at different times before (t < 0 min) and 
following addition of 0.5 mM caffeine in the absence (A) and presence (B) of 10 μM dantrolene.  
Figure 7. Families of normalized current traces obtained from the double pulse protocol in response 
to caffeine challenge at a concentration of 2 mM in the absence (A, B) or the presence (C, D) of 10 
μM dantrolene. (A, C) Control traces obtained in KH solution, prior to caffeine challenge. (B, D) 
Families of records obtained at successive (i) 3 or 5 min, (ii) 19 or 21 min and (iii) 29 or 31 min after 
addition of 2 mM caffeine-containing KH solution into the bath in (B) the absence or (D) presence of 
dantrolene.  
Figure 8. Activation (left panels) and inactivation I-V curves (right panels) (mean of I1 or I2 ± 
standard error of mean (SEM)) against each V1 excursion before (i) and following (ii) introduction of 
2 mM caffeine in the absence (A) or the presence (B) of 10 μM dantrolene. Families of INa records 
were obtained  2-15 min (ii), 16-25 min  (iii), and 26-40 min (iv)  after adding 2 mM caffeine. 
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Figure 9. Alterations in (i) Imax, (ii) V* and (iii) k derived from current-voltage (I-V) activation (left 
panels) and inactivation (right panels) followed from successive patches studied at different times 
before (t < 0 min) and following addition of 2 mM caffeine in the absence  (A) and presence (B) of 10 
μM dantrolene,.  
Figure 10. Correlation between observed ryanodine receptor (RyR) agonist and antagonist 
actions and (A) Feedforward Nav1.5 mediated depolarisation triggering DHPR-RyR coupling 
causing SR Ca
2+
 release that is (B) inhibited by RyR-antagonist dantrolene, and previous 
studies reporting: (C, D) Challenge by (C) 0.5 mM caffeine increasing RyR-mediated Ca
2+
 
release and FKBP12 dissociation reducing Nav1.4 availability thereby modifying Nav1.4 
properties and (D) 2 mM caffeine, where Ca
2+
 release causes sustained RyR inactivation with 
net SR Ca
2+
 uptake, reduced FKBP12 dissociation, and contrasting Nav1.4 effects. Blue 
arrows: fluxes; green and red dotted arrows: excitatory and inhibitory actions.  
  
30 
 
 
Figure 1 
 
 
  
31 
 
 
Figure 2 
 
 
 
32 
 
Figure 3 
 
 
 
 
33 
 
Figure 4 
 
 
34 
 
Figure 5 
 
 
35 
 
 
36 
 
Figure 6  
37 
 
Figure 7 
 
 
38 
 
Figure 8 
 
39 
 
Figure 9 
 
40 
 
 
Figure 10 
 
 
